These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 21956115)

  • 41. Benzothiazole hydrazones of furylbenzamides preferentially stabilize c-MYC and c-KIT1 promoter G-quadruplex DNAs.
    Pany SP; Bommisetti P; Diveshkumar KV; Pradeepkumar PI
    Org Biomol Chem; 2016 Jun; 14(24):5779-93. PubMed ID: 27021281
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The Consequences of Overlapping G-Quadruplexes and i-Motifs in the Platelet-Derived Growth Factor Receptor β Core Promoter Nuclease Hypersensitive Element Can Explain the Unexpected Effects of Mutations and Provide Opportunities for Selective Targeting of Both Structures by Small Molecules To Downregulate Gene Expression.
    Brown RV; Wang T; Chappeta VR; Wu G; Onel B; Chawla R; Quijada H; Camp SM; Chiang ET; Lassiter QR; Lee C; Phanse S; Turnidge MA; Zhao P; Garcia JGN; Gokhale V; Yang D; Hurley LH
    J Am Chem Soc; 2017 Jun; 139(22):7456-7475. PubMed ID: 28471683
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Discovery of a New Four-Leaf Clover-Like Ligand as a Potent c-MYC Transcription Inhibitor Specifically Targeting the Promoter G-Quadruplex.
    Hu MH; Wang YQ; Yu ZY; Hu LN; Ou TM; Chen SB; Huang ZS; Tan JH
    J Med Chem; 2018 Mar; 61(6):2447-2459. PubMed ID: 29474069
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Disubstituted 1,8-dipyrazolcarbazole derivatives as a new type of c-myc G-quadruplex binding ligands.
    Chen WJ; Zhou CX; Yao PF; Wang XX; Tan JH; Li D; Ou TM; Gu LQ; Huang ZS
    Bioorg Med Chem; 2012 May; 20(9):2829-36. PubMed ID: 22484007
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Disabling c-Myc in childhood medulloblastoma and atypical teratoid/rhabdoid tumor cells by the potent G-quadruplex interactive agent S2T1-6OTD.
    Shalaby T; von Bueren AO; Hürlimann ML; Fiaschetti G; Castelletti D; Masayuki T; Nagasawa K; Arcaro A; Jelesarov I; Shin-ya K; Grotzer M
    Mol Cancer Ther; 2010 Jan; 9(1):167-79. PubMed ID: 20053783
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Truncated G-Quadruplex Isomers Cross-Talk with the Transcription Factors To Maintain Homeostatic Equilibria in c-MYC Transcription.
    Sengupta P; Bhattacharya A; Sa G; Das T; Chatterjee S
    Biochemistry; 2019 Apr; 58(15):1975-1991. PubMed ID: 30920805
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Structures of 1:1 and 2:1 complexes of BMVC and MYC promoter G-quadruplex reveal a mechanism of ligand conformation adjustment for G4-recognition.
    Liu W; Lin C; Wu G; Dai J; Chang TC; Yang D
    Nucleic Acids Res; 2019 Dec; 47(22):11931-11942. PubMed ID: 31740959
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Design, Synthesis, and Evaluation of New Selective NM23-H2 Binders as c-MYC Transcription Inhibitors via Disruption of the NM23-H2/G-Quadruplex Interaction.
    Wang YQ; Huang ZL; Chen SB; Wang CX; Shan C; Yin QK; Ou TM; Li D; Gu LQ; Tan JH; Huang ZS
    J Med Chem; 2017 Aug; 60(16):6924-6941. PubMed ID: 28714689
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Stabilization of G-quadruplex DNA with platinum(II) Schiff base complexes: luminescent probe and down-regulation of c-myc oncogene expression.
    Wu P; Ma DL; Leung CH; Yan SC; Zhu N; Abagyan R; Che CM
    Chemistry; 2009 Dec; 15(47):13008-21. PubMed ID: 19876976
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Topoisomerase 1 inhibits MYC promoter activity by inducing G-quadruplex formation.
    Keller JG; Hymøller KM; Thorsager ME; Hansen NY; Erlandsen JU; Tesauro C; Simonsen AKW; Andersen AB; Vandsø Petersen K; Holm LL; Stougaard M; Andresen BS; Kristensen P; Frøhlich R; Knudsen BR
    Nucleic Acids Res; 2022 Jun; 50(11):6332-6342. PubMed ID: 35687110
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Small Molecule Microarrays Enable the Identification of a Selective, Quadruplex-Binding Inhibitor of MYC Expression.
    Felsenstein KM; Saunders LB; Simmons JK; Leon E; Calabrese DR; Zhang S; Michalowski A; Gareiss P; Mock BA; Schneekloth JS
    ACS Chem Biol; 2016 Jan; 11(1):139-48. PubMed ID: 26462961
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Syntheses and Evaluation of New Bisacridine Derivatives for Dual Binding of G-Quadruplex and i-Motif in Regulating Oncogene
    Kuang G; Zhang M; Kang S; Hu D; Li X; Wei Z; Gong X; An LK; Huang ZS; Shu B; Li D
    J Med Chem; 2020 Sep; 63(17):9136-9153. PubMed ID: 32787078
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Perylene and coronene derivatives binding to G-rich promoter oncogene sequences efficiently reduce their expression in cancer cells.
    Micheli E; Altieri A; Cianni L; Cingolani C; Iachettini S; Bianco A; Leonetti C; Cacchione S; Biroccio A; Franceschin M; Rizzo A
    Biochimie; 2016 Jun; 125():223-31. PubMed ID: 27086081
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Identification and characterization of nucleolin as a c-myc G-quadruplex-binding protein.
    González V; Guo K; Hurley L; Sun D
    J Biol Chem; 2009 Aug; 284(35):23622-35. PubMed ID: 19581307
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Recent Update on Targeting
    Chaudhuri R; Bhattacharya S; Dash J; Bhattacharya S
    J Med Chem; 2021 Jan; 64(1):42-70. PubMed ID: 33355454
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cell penetrating thiazole peptides inhibit c-MYC expression via site-specific targeting of c-MYC G-quadruplex.
    Dutta D; Debnath M; Müller D; Paul R; Das T; Bessi I; Schwalbe H; Dash J
    Nucleic Acids Res; 2018 Jun; 46(11):5355-5365. PubMed ID: 29762718
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Gaining insights into the small molecule targeting of the G-quadruplex in the c-MYC promoter using NMR and an allele-specific transcriptional assay.
    Kaiser CE; Gokhale V; Yang D; Hurley LH
    Top Curr Chem; 2013; 330():1-21. PubMed ID: 22752577
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Deregulation of the proto-oncogene c-myc through t(8;22) translocation in Burkitt's lymphoma.
    Gerbitz A; Mautner J; Geltinger C; Hörtnagel K; Christoph B; Asenbauer H; Klobeck G; Polack A; Bornkamm GW
    Oncogene; 1999 Mar; 18(9):1745-53. PubMed ID: 10208435
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Structure-based design of platinum(II) complexes as c-myc oncogene down-regulators and luminescent probes for G-quadruplex DNA.
    Wang P; Leung CH; Ma DL; Yan SC; Che CM
    Chemistry; 2010 Jun; 16(23):6900-11. PubMed ID: 20437426
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Discovery of Novel 11-Triazole Substituted Benzofuro[3,2-b]quinolone Derivatives as c-myc G-Quadruplex Specific Stabilizers via Click Chemistry.
    Zeng DY; Kuang GT; Wang SK; Peng W; Lin SL; Zhang Q; Su XX; Hu MH; Wang H; Tan JH; Huang ZS; Gu LQ; Ou TM
    J Med Chem; 2017 Jul; 60(13):5407-5423. PubMed ID: 28514170
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.